Heather Malcolm
Director/Miembro de la Junta en Montana Council on Economic Education .
Perfil
Heather Malcolm is currently the Director at Montana Council on Economic Education.
Prior to this, she worked as the Vice President-Human Resources at Lundbeck Seattle BioPharmaceuticals, Inc. from 2008 to 2019.
Ms. Malcolm completed her undergraduate degree from St. John's College in 1994.
Cargos activos de Heather Malcolm
Empresas | Cargo | Inicio |
---|---|---|
Montana Council on Economic Education
Montana Council on Economic Education Investment Trusts/Mutual FundsMiscellaneous Montana Council on Economic Education focuses on teacher education. The firm hosts training sessions throughout the year including workshops, conferences and seminars. Its programs include Teacher Training, High School Business Challenge, and The Stock Market Game. The company is headquartered in Bozeman, MT. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Heather Malcolm.
Empresas | Cargo | Fin |
---|---|---|
ALDER BIOPHARMACEUTICALS, INC. | Oficial de Recursos Humanos | 01/12/2019 |
Formación de Heather Malcolm.
St. John's College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Montana Council on Economic Education
Montana Council on Economic Education Investment Trusts/Mutual FundsMiscellaneous Montana Council on Economic Education focuses on teacher education. The firm hosts training sessions throughout the year including workshops, conferences and seminars. Its programs include Teacher Training, High School Business Challenge, and The Stock Market Game. The company is headquartered in Bozeman, MT. | Miscellaneous |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Heather Malcolm